US Closing in on 350,000 Daily COVID-19 Vaccine Doses

Article

The US currently leads all countries in total vaccine administrations as of the first week of 2021.

An original version of this article was published by sister publication Contagion.

The US has administered more than 4.5 million doses of coronavirus 2019 (COVID-19) vaccine to its population as of Monday, January 4, per estimated counts from the US Centers for Disease Control and Prevention (CDC) and University of Oxford.

While discussion surrounding the distribution of recently-authorized two-dose mRNA vaccines BNT162b2 from Pfizer and BioNTech, and mRNA-1273 from Moderna, has focused on the merits of single-dose versus standard administration, the nation has increased its daily vaccination count from approximately 235,000-348,000 in just 1 week.

Presently, the very small countries of Israel and Bahrain are reporting a substantial vaccination count per capita, while the United States improves on a slow rollout start.

United States
4.56 million
1.38 per 100
China
4.5 million
0.31 per 100
Israel
1.22 million
14.14 per 100
United Kingdom
944,539
1.39 per 100
Russia
800,000
0.55 per 100
Germany
265,610
0.32 per 100
Italy
128,880
0.21 per 100
Canada
117,768
0.31 per 100
Spain
82,834
0.18 per 100
Bahrain
61,612
3.62 per 100

Data per Our World in Data (Jan 5, 2021, 12 AM EST)

Unsurprisingly, among the most vaccinated states thus far are California, Texas, and New York—large, highly populated regions notably affected during various waves of the pandemic since March 2020.

California
451,702
1.14 per 100
Texas
374,238
1.29 per 100
New York
274,713
1.41 per 100
Florida
264,512
1.23 per 100
Colorado
262,275
1.95 per 100
Illinois
176,577
1.39 per 100
Pennsylvania
163,207
1.28 per 100
Ohio
159,869
1.37 per 100
Tennessee
152,516
2.23 per 100
Massachusetts
110,279
1.60 per 100

Data per CDC COVID-19 Tracker (Jan 4, 2021, 9 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

What More COVID-19 Testing Can Do for 2021

Moderna Vaccine Shows Significant COVID-19 Prevention Efficacy in Phase 3 Data

UK Approves Emergency Authorization for the AstraZeneca and Oxford COVID-19 Vaccine

Related Videos
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.